Implanet SA (ALIMP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Implanet SA (ALIMP) has a cash flow conversion efficiency ratio of 0.224x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-306.00K ≈ $-357.75K USD) by net assets (€-1.36 Million ≈ $-1.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Implanet SA - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Implanet SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Implanet SA carry for a breakdown of total debt and financial obligations.
Implanet SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Implanet SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Softcat plc
LSE:SCT
|
0.435x |
|
Dimension Computer Technology Co Ltd
TWO:6140
|
0.186x |
|
EG Corporation
KQ:037370
|
-0.217x |
|
SuperCom Ltd
F:50S
|
-0.056x |
|
Cemat A/S
CO:CEMAT
|
0.066x |
|
Rand Capital Corp
NASDAQ:RAND
|
0.009x |
|
Chumpower Machinery Corp
TWO:4575
|
0.030x |
|
Precision Optics Corporation, Inc. Common stock
NASDAQ:POCI
|
-0.027x |
Annual Cash Flow Conversion Efficiency for Implanet SA (2012–2024)
The table below shows the annual cash flow conversion efficiency of Implanet SA from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Implanet SA market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €727.00K ≈ $849.94K |
€-2.32 Million ≈ $-2.72 Million |
-3.197x | -138.44% |
| 2023-12-31 | €-174.00K ≈ $-203.42K |
€-1.45 Million ≈ $-1.69 Million |
8.316x | +1324.93% |
| 2022-12-31 | €3.54 Million ≈ $4.14 Million |
€-2.40 Million ≈ $-2.81 Million |
-0.679x | +45.84% |
| 2021-12-31 | €2.80 Million ≈ $3.28 Million |
€-3.52 Million ≈ $-4.11 Million |
-1.254x | +58.26% |
| 2020-12-31 | €1.02 Million ≈ $1.19 Million |
€-3.07 Million ≈ $-3.59 Million |
-3.003x | -53.51% |
| 2019-12-31 | €1.44 Million ≈ $1.68 Million |
€-2.81 Million ≈ $-3.28 Million |
-1.956x | -5.80% |
| 2018-12-31 | €2.40 Million ≈ $2.81 Million |
€-4.44 Million ≈ $-5.19 Million |
-1.849x | -160.38% |
| 2017-12-31 | €6.29 Million ≈ $7.35 Million |
€-4.46 Million ≈ $-5.22 Million |
-0.710x | -16.42% |
| 2016-12-31 | €9.66 Million ≈ $11.29 Million |
€-5.89 Million ≈ $-6.89 Million |
-0.610x | +12.91% |
| 2015-12-31 | €9.73 Million ≈ $11.37 Million |
€-6.81 Million ≈ $-7.96 Million |
-0.700x | +4.55% |
| 2014-12-31 | €7.21 Million ≈ $8.43 Million |
€-5.29 Million ≈ $-6.19 Million |
-0.734x | -88.93% |
| 2013-12-31 | €13.87 Million ≈ $16.21 Million |
€-5.39 Million ≈ $-6.30 Million |
-0.388x | +54.44% |
| 2012-12-31 | €4.68 Million ≈ $5.47 Million |
€-3.99 Million ≈ $-4.66 Million |
-0.852x | -- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fix… Read more